nathan davis executive director medreleaf australia drive change

Our GPs are continually frustrated by the current driving laws that prevent them from offering a safe and effective alternative to commonly prescribed and sedating compounds such as opioids and benzodiazepines. We need to have confidence that GPs are more than capable of managing a patients therapy, whether the patient wishes to drive to work or otherwise.

Nathan Davis

Executive Director, MedReleaf Australia
Recent posts

Working and driving rights are human rights

If your prescribed medicine prevents you from driving and working, what does that mean for your human rights? The UK’s Cannabis Industry Council released a report this week into workplace issues for medicinal cannabis patients who are regarded as disabled under UK work, health and safety laws. Despite its specificity, it is a worthwhile read […]

Read more

Precarious working lives and longest days

Drive Change’s David Heilpern got some great soundbites in last Saturday morning and ABC News ran them on the hour, every hour, all day. This is the benefit of having elected reps in Victoria, WA and NSW bringing on topical parliamentary debates on cannabis law reform. Journalists will ring us to discuss this News, interview […]

Read more